Drug Policy in India by Tripti Tandon, Deputy Director, Lawyers Collective

Total Page:16

File Type:pdf, Size:1020Kb

Drug Policy in India by Tripti Tandon, Deputy Director, Lawyers Collective BRIEFINGBriefing PAPER paper February 2015 Drug policy in India By Tripti Tandon, Deputy Director, Lawyers Collective Introduction references to cannabis use dating back to 2000 B.C. Post-colonization, the British attempted India’s response to drugs flows along an to regulate it through excise laws that licensed extraordinary spectrum – of tradition and cultivation and imposed taxes on the sale of modernity; of widespread availability and hemp.2 The cultivation and use of opium is stringent enforcement; of tolerance and believed to date as far back as the 10th century. prohibition; of production for medical use to During the colonial period, the British organized lack of medical access to opiates. India’s long opium into a large-scale commercial enterprise, history of cannabis and opium use is referenced consolidating and bringing cultivation of poppy extensively in policy analysis.1 Being a country and manufacture of opium (but not consumption) with significant volumes of licit and illicit drug under greater control through the Opium Acts of cultivation, a transit route as well as a consumer 1857 and 1878.3 market, India’s drug policy dilemmas span ‘demand’ and ‘supply’ control. Its large chemical By the 1920s, the growing nationalist movement and pharmaceutical industry draws the country became critical of the colonial government’s into deliberations on the illicit manufacture of commercially driven drug policy. Indian leaders drugs and precursor control as well as the non- distanced themselves from traditional use and medical use of prescription drugs. Some parts of the eradication of drugs became an avowed the country report alarmingly high rates of drug policy goal.4 Many provincial governments passed dependence, HIV and viral hepatitis amongst laws to restrict the consumption of opium.5 people who inject drugs, making health and harm Cannabis was classified as an intoxicating drug reduction important policy considerations. While and continued to be regulated through provincial India’s harsh drug control laws (in particular the excise Acts.6 criminalization of drug use and the imposition of the death penalty for certain drug offences) In 1930, the Dangerous Drugs Act was enacted conform strictly with prohibition, its regulated opium cultivation industry provides insights for and sought to extend and strengthen control countries that are experimenting with alternatives over drugs derived from coca, hemp (cannabis) to prohibition. and poppy plants by regulating the cultivation, possession, manufacture, sale, domestic trade and external transactions through licenses and Context penalizing unlicensed activities.7 There were Cannabis has been consumed for spiritual, no offences attached to cannabis or to drug medicinal and recreational purposes in India consumption. The framework of the Dangerous since the classical era, with earliest documented Drugs Act continues to prevail in the current 1 legislation, especially the statutory definitions Current legal framework for coca, opium, hemp and their derivatives, the category of “manufactured drugs” and the Narcotic Drugs and Psychotropic division of rule-making powers between the Substances Act, 1985 central and state governments. India is a party to the three United Nations drug conventions – the 1961 Single Convention on The Drugs and Cosmetics Act, 19408 was adopted Narcotic Drugs (1961 Convention), the 1971 for the regulation of medicinal drugs including Convention on Psychotropic Substances (1971 cannabis and opium. The Dangerous Drugs Act, Convention) and the 1988 Convention against however, continued to apply. Illicit Traffic in Narcotic Drugs and Psychotropic Substances (1988 Convention). Domestic At the time of independence, gained in 1947, legislation to give effect to these treaties was narcotics were a heavily regulated commodity as introduced only in the 1980s when the ‘grace ‘dangerous’ substances, medicinal products, as period’ for abolishing non-medical use of cannabis well as goods subject to excise tax. and opium under the 1961 Convention expired.15 Exercising its powers to make law for the country This position continued post-independence. With for implementing “any treaty, agreement or the adoption of the Indian Constitution in 1950, convention or decision made at international all laws became subordinate to constitutional conference”,16 the Indian Parliament passed the provisions, in particular, fundamental rights.9 There Narcotic Drugs and Psychotropic Substances Act, were some challenges to drug laws on the grounds 1985 (NDPS Act) hastily, without much debate. that they were discriminatory and contravened The NDPS Act came into force on 14 November farmers’ freedom of trade and occupation. The 1985, replacing the Opium Acts and the Dangerous cases, however, were unsuccessful.10 Courts relied, Drugs Act. The 1940 Drugs and Cosmetics Act, among other things, on India’s international drug 1940, however, continues to apply.17 control commitments to justify the restrictions on cultivation, use and trade. The official record states that the NDPS Act was enacted in order to provide adequate penalties The prohibitionist sentiment became further for drug trafficking, strengthen enforcement entrenched by way of Article 47 of the Constitution powers, implement international conventions to which states: “The State shall endeavor to bring which India was a party, and enforce controls over about prohibition of the consumption except for psychotropic substances. The Act was amended medicinal purposes of intoxicating drinks and of in 1989, 2001 and more recently in 2014. drugs which are injurious to health”. Although these Directive Principles of State Policy are non- The NDPS Act prohibits cultivation, production, enforceable,11 this provision is frequently invoked possession, sale, purchase, trade, import, to justify punitive drug policies. export, use and consumption of narcotic drugs and psychotropic substances except for medical The Constitution also earmarked subjects on and scientific purposes in accordance with the which Parliament or state Legislatures could law.18 Preparation to commit certain offences make law either exclusively or concurrently. is punishable as is attempt. Accessory crimes “Drugs and poisons” was placed in the of aiding and abetting and criminal conspiracy concurrent list,12 allowing both center and attract the same punishment as the principal states to legislate. “Public health” and “prisons offence.19 and other institutions of like nature and persons detained therein” are only on the state list.13 The Act covers three broad classes of substances: The division of legislative powers is significant 1) narcotic drugs, that is, those covered under because it determines state governments’ the 1961 Convention; 2) psychotropic substances ability to ‘break’ from national drug policies and or those covered under the 1971 Convention employ alternatives14 in areas where they are as well as other psychoactive substances such empowered to frame policy. as ketamine which are not yet classified under 2 international conventions; and 3) “controlled empowers the central and state governments to substances”20 that are used to manufacture frame rules26 and authorize drug-related activities narcotic drugs or psychotropic substances, for within the rubric of “medical and scientific example precursor chemicals such as acetic purpose”, a term which is neither defined nor anhydride, ephedrine and pseudoephedrine. described in the Act. While some activities are reserved exclusively for the government,27 others Narcotic drugs include: can be carried out by private entities under 28 • Cannabis: plant; resin or charas and its license. The regulatory system also includes concentrated variant called hashish; dried supply of opium to registered users, who are flowering or fruiting tops of the plant, that dependent on opium, for consumption on medical is, ganja and any mixture of charas or ganja. advice – a measure comparable to contemporary 29 Importantly, bhang or the cannabis leaf harm reduction strategies. Though provided in 30 is excluded (in accordance with the 1961 the law, the practice has fallen into disuse and Convention) and regulated through state as of last year, there were less than 1,000 opium 31 excise laws users registered in the entire country. • Coca: plant: leaf; derivatives include cocaine In 1988, the NDPS Act was supplemented by and any preparation containing 0.1% of the Prevention of Illicit Traffic in Narcotic Drugs cocaine and Psychotropic Substances Act to provide for • Opium: poppy plant; poppy straw; preventive detention of people suspected or concentrated poppy straw; juice of accused of involvement in drug trafficking.32 opium poppy; mixture of opium poppy juice; preparations with 0.2% morphine; NDPS Amendments, 1989 derivatives include heroin, morphine, In 1989, the NDPS Act underwent the first codeine, thebaine, etc. set of amendments, after a Cabinet Sub- Committee for combating drug trafficking and Narcotic drugs also fall under the overlapping abuse recommended that the law be made category of “manufactured drugs”.21 Psycho- more stringent. The ‘tough on drugs’ rhetoric tropic drugs are not defined but include all led to the introduction of very harsh provisions drugs notified by the government as such. such as mandatory minimum sentences of 10 Amphetamines, methamphetamines, LSD, MDMA years’ imprisonment, restrictions on bail, bar and buprenorphine amongst others are on on suspension and commutation of sentences, this list, which
Recommended publications
  • Cannabis (Sub)Culture, the Subcultural Repository, and Networked Mediation
    SIMULATED SESSIONS: CANNABIS (SUB)CULTURE, THE SUBCULTURAL REPOSITORY, AND NETWORKED MEDIATION Nathan J. Micinski A Thesis Submitted to the Graduate College of Bowling Green State University in partial fulfillment of the requirements for the degree of MASTER OF ARTS May 2014 Committee: Ellen Berry, Advisor Rob Sloane © 2014 Nathan Micinski All Rights Reserved iii ABSTRACT Ellen Berry, Advisor Subcultural theory is traditionally rooted in notions of social deviance or resistance. The criteria for determining who or what qualifies as subcultures, and the most effective ways to study them, are based on these assumptions. This project seeks to address these traditional modes of studying subcultures and discover ways in which their modification may lead to new understandings and ways of studying subcultures in the contemporary moment. This will be done by suggesting a change in the criteria of examining subcultures from that of deviance or resistance to identification with a collection of images, symbols, rituals, and narratives. The importance of this distinction is the ability to utilize the insights that studying subcultures can offer while avoiding the faults inherent in speaking for or at a subculture rather than with or from it. Beyond addressing theoretical concerns, this thesis aims to apply notions of subcultural theory to study the online community of Reddit, in particular, a subset known as r/trees–a virtual repository for those images, symbols, rituals, and narratives of cannabis subculture. R/trees illustrates the life and vibrancy of a unique subcultural entity, which to this point has evaded a cultural studies analysis. To that end, this project advocates for the importance of the cultural studies approach to analyzing cannabis subculture and further, to insert the findings of this study into that gap in the literature.
    [Show full text]
  • Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017
    Guide to Worker Safety and Health in the Marijuana Industry Marijuana Occupational Health and Safety Work Group January 2017 colorado.gov/cdphe/marijuana-occupational-safety-health Guide to Worker Safety and Health in the Marijuana Industry: 2017 About this guide This guide is intended to help assist employers in the marijuana industry build occupational safety and health programs. While the foundation of this guide includes existing Colorado state and federal regulations, it is not a comprehensive guide to all of the regulations pertaining to occupational safety and health. It should be noted that this guide does not present any new occupational safety and health regulations for the marijuana industry. Marijuana cultivators, extractors, labs and retailers are required to adhere to all regulations established by the Colorado Department of Revenue’s Marijuana Enforcement Division (MED) https://www.colorado.gov/pacific/enforcement/laws-constitution-statutes-and-regulations-marijuana- enforcement. The marijuana industry in Colorado falls under federal OSHA jurisdiction and businesses must comply with OSHA regulations and recordkeeping requirements. In addition to OSHA regulations, marijuana businesses are required to comply with other state regulations including Colorado labor laws, Colorado workers’ compensation laws, Colorado hazardous waste laws, Colorado Pesticide Applicator’s Act, local fire codes, and other regulations that are specific to employment and labor as well as the production of retail and medical marijuana. Guide to Worker Safety and Health in the Marijuana Industry: 2017 About the Colorado Marijuana Occupational Health and Safety Work Group The Colorado Marijuana Occupational Health and Safety Work Group is a multidisciplinary group that was convened to draw on expertise and experiences of many professionals in the Colorado community.
    [Show full text]
  • (A-9-THC) Content in Herbal Cannabis Over Time
    32 Current Drug Abuse Reviews, 2012, 5, 32-40 Increasing Delta-9-Tetrahydrocannabinol (-9-THC) Content in Herbal Cannabis Over Time: Systematic Review and Meta-Analysis Fidelia Cascini*,1, Carola Aiello2 and GianLuca Di Tanna3 1Istituto di Medicina Legale, Università Cattolica del S. Cuore, largo F. Vito, 1 00168 Roma, Italy 2Department of Informatics and Systemics, University ‘La Sapienza’, 00185 Rome, Italy 3Department of Public Health and Infectious Diseases, University "La Sapienza", 00185, Rome, Italy Abstract: Aim: The objective of this meta-analysis is to assess the data regarding changes in herbal cannabis potency over time (from 1970 to 2009). Methods: Systematic searches of 17 electronic scientific databases identified studies on this topic, within which 21 case series studies satisfied our inclusion criteria of reporting the mean tetrahydrocannabinol (THC) value per number of samples per year. No language, publication date, publication type or status restrictions were imposed. The study selection and data extraction processes were performed independently but uniformly by two authors, included screening, determination of eligibility and inclusion of the eligible studies in the systematic review, and a meta-analysis of the results on THC content in herbal cannabis samples. We considered papers and not monographic scientific publications, rejecting all studies that were not focused on the subject of this review. Results: Meta-analysis by year was performed on 21 studies containing 75 total mean THC observations from 1979 to 2009 using the random effects model. The results revealed much variability between studies. Further, there was a significant correlation between year and mean THC in herbal cannabis. The combined data indicated the correlation between year and mean THC in herbal cannabis, revealing a temporal trend of increasing potency (5% above the mean THC value in the Poisson regression analysis).
    [Show full text]
  • Marijuana: What the Evidence Shows at It Relates to the Impact of Use and What Can Be Learned from Washington State and Colorado.”
    Kevin A. Sabet, Ph.D. Director, University of Florida Drug Policy Institute, Department of Psychiatry, Division of Addiction Medicine Director, Project SAM (Smart Approaches to Marijuana) Author, Reefer Sanity: Seven Great Myths About Marijuana Before the House and Senate Judiciary Committees, State of Oregon January 17, 2013 Written Testimony “Marijuana: What the evidence shows at it relates to the impact of use and what can be learned from Washington State and Colorado.” Chairman and distinguished members of the Committee, thank you for providing me with the opportunity to appear before you today to discuss marijuana policy and appropriate federal responses. I have studied, researched, and written about drug policy, drug markets, drug prevention, drug treatment, criminal justice policy, addiction, and public policy analysis for almost 18 years. Most recently, from 2009-2011, I served in the Obama Administration as a senior drug policy advisor. I am currently the co-founder, with former Congressman Patrick J. Kennedy, of Project SAM (Smart Approaches to Marijuana). I am also the author of Reefer Sanity: Seven Great Myths About Marijuana (Beaufort). In fact, in my new book, I outline the precise reasons why we in the Obama Administration rejected legalization time and time again when presented with it. Our experience, when talking with parents, prevention and treatment providers, medical associations, law enforcement, and others, was that opening up a legal market for any current illicit drug would be disastrous for public health and safety. Indeed, in the Obama Administration’s inaugural and subsequent drug control strategies, marijuana legalization is explicitly rejected. That is why numerous groups and I found the recent guidance by the U.S.
    [Show full text]
  • 4Hr Course Outline: Marijuana Update
    4HR COURSE OUTLINE: MARIJUANA UPDATE *CONCENTRATED CANNABIS* Goals and Objectives: The course will cover current techniques and trends associated with the manufacturing, packaging and sales of concentrated cannabis. This course will also outline dangers associated with the manufacturing of butane honey oil, as well as the dangers associated with alcohol based solvents used in the extraction process of concentrated cannabis. I. Registration and Orientation. A. Introduction B. Course Objectives II. Hash oil, or concentrated cannabis? A. What is hash oil or concentrated cannabis? B. How is it made? 1. Chemicals used in the extraction 2. Different manufacturing techniques C. Slang terms/names for hash oils III. Why concentrated cannabis? A. THC percentages B. Transportation concerns C. Monetary values 4HR COURSE OUTLINE: MARIJUANA UPDATE *CONCENTRATED CANNABIS* IV. Chemical properties and purity of solvents. A. Impurities in solvents that affect outcomes of extraction 1. Water 2. Fill Chemicals 3. Additives B. Polarity of solvents 1. Polar solvents 2. Non-polar solvents 3. Semi-polar solvents C. Solvents 1. Water 2. Ethyl/ethanol/grain alcohol 3. Isopropyl alcohol 4. Hexane 5. Propane 6. Butane V. Bubble hash and Kief hash A. Bubble hash 1. How it’s manufactured 2. Forms 3. Dollar amounts B. Kief hash 1. How it’s manufactured 2. Forms 3. Dollar amounts 4HR COURSE OUTLINE: MARIJUANA UPDATE *CONCENTRATED CANNABIS* VI. Applicable California law A. California Health and Safety Code 11379.6 B. California Penal Code 452(a) C. California Penal Code 452(b) VII. Butane honey oil extraction A. Butane facts 1. Boiling point 2. Flashpoint 3. Explosive limits of butane 4.
    [Show full text]
  • HOUSE BILL No. 2184
    Session of 2021 HOUSE BILL No. 2184 By Committee on Federal and State Affairs 2-1 1 AN ACT concerning health and healthcare; enacting the Kansas medical 2 marijuana regulation act; relating to medical cannabis; licensure and 3 regulation of the manufacture, transportation and sale of medical 4 cannabis; providing certain fines and penalties for violations; amending 5 K.S.A. 44-1009, 44-1015, 65-28b08, 79-5201 and 79-5210 and K.S.A. 6 2020 Supp. 21-5703, 21-5705, 21-5706, 21-5707, 21-5709, 21-5710, 7 23-3201, 38-2269, 44-501, 44-706 and 65-1120 and repealing the 8 existing sections. 9 10 Be it enacted by the Legislature of the State of Kansas: 11 New Section 1. The provisions of sections 1 through 46, and 12 amendments thereto, shall be known and may be cited as the Kansas 13 medical marijuana regulation act. 14 New Sec. 2. As used in the Kansas medical marijuana regulation act, 15 section 1 et seq., and amendments thereto: 16 (a) "Academic medical center" means a medical school and its 17 affiliated teaching hospitals and clinics. 18 (b) "Associated employee" means an owner or prospective owner, 19 officer or board member or prospective board member of an entity seeking 20 a retail dispensary license. 21 (c) "Board of healing arts" means the state board of healing arts. 22 (d) "Caregiver" means an individual registered pursuant to section 8, 23 and amendments thereto, who may purchase and possess medical 24 marijuana in accordance with section 11, and amendments thereto.
    [Show full text]
  • Quarterly Report Potency Monitoring Project Report
    QUARTERLY REPORT POTENCY MONITORING PROJECT REPORT 104 December 16, 2008 thru March 15, 2009 National Institute on Drug Abuse Contract Number: NOJDA-5-7746 02 /lltf~ Mabm't:. EISobJ;,II:D: Director NIDA Marijuana Project National Center for Natural Products Research a Division of the Resean:b Institute of Pharmaceutical Sciences The School of Pharmacy University of Mississippi University, Mississippi 38677 TABLE OF CONTENTS List of Figures ............................................................................................................................... 3 Summary ................................................................................................................................ 4 Introduction ................................................................................................................................ 5 Table 1. Prevalence of High Potency Marijuana (1989-Present) Between December 16, 2008 to March 15, 2009 ................................................ 7 Table 2. Non-normalized Cannabinoid Averages of Illicit Cannabis Samples by Year Seized ...................................................................................................... 8 Table 3. Comparison of Non-normalized 9-THC Concentration in Different Forms by year Confiscated, 1985-2008 .............................................................. 10 Table 4. Non-normalized 9-THC Averages of Illicit Cannabis Samples Analyzed through March 15, 2009(PM vs. ST) ................................................. 11 Table 5. Domestic
    [Show full text]
  • Maine Marijuana Education Toolkit
    Marijuana Education Toolkit Preventing Underage and High Risk Use July 2020 About This Toolkit The use, sale, and possession of marijuana for those 21 and over is legal in Maine. On November 8, 2016, Maine voters approved Question 1 allowing the legalized use, retail sale, and taxation of marijuana. In 2019, licenses for adult use retail sale, manufacture, and operations were made available. Maine has a robust community of public health professionals who use passion and expertise in their work to prevent tobacco and substance use in their communities, and who know it will take a comprehensive, multi-faceted approach to address the increased visibility and shifting norms that accompany legalization of adult use marijuana. This marijuana toolkit aims to provide community members and prevention educators with essential information and supportive resources. This toolkit is intended to be included in broader community prevention education efforts. Preventing initiation of marijuana use among young people, as well as limiting problematic use, will take the effort of entire communities. This toolkit: • Provides information on health impacts, legal considerations, safety issues, and delves into elements of the cannabis plant, including the psychoactive and non-psychoactive components. • Uses cannabis and marijuana interchangeably, however the legal term for the product regulated and licensed in the state of Maine is marijuana. • Refers to adult use (rather than recreational use) in reference to use and possession for those over 21. Federally, marijuana remains a Schedule 1 Drug and continues to be illegal under federal law even though the state of Maine has voted to legalize adult use and retail sales.
    [Show full text]
  • The “Green Gold Rush”
    ACKRELL CAPITAL U.S. CANNABIS INVESTMENT REPORT 2016 The “Green Gold Rush” Contents n Foreword I Executive Summary II Legislative Landscape; Legal Issues for Investor Consideration III Cannabis 101 IV U.S. Cannabis Market Estimates Overview V Industry Segmentation VI Capital Markets for Cannabis Companies • Cannabis is federally illegal in the United States. However, as of VII Top 100 Private Cannabis Companies 2016 the date of this report, 39 states have legalized cannabis in some form for recreational or medicinal use. VIII Industry Risk Factors • The current consumer market for recreational and medicinal IX Glossary of Terms cannabis in the United States is estimated to be more than n Disclosures, Disclaimers, Sources and Use of This Report $40 billion, including both legal and illegal consumption. n Ackrell Capital Team Leaders • We believe that it is a question of when—not if—the federal prohibition on cannabis will end. In analyzing how the end of n Inside Back Cover: The Green Field 2016 prohibition may affect the cannabis industry, we have assumed that prohibition ends by 2020. However, even with federal pro- hibition, the cannabis industry today is large and dynamic. About Ackrell Capital • We estimate that the U.S. cannabis consumer market for legal- ized recreational and medicinal use was $4.4 billion in 2015 Founded in 2003, Ackrell Capital is a leading independent invest- and will grow to $9.5 billion in 2019. Once legalized federally, ment bank focused on emerging growth companies. Ackrell Capi- we estimate this market will grow to $37 billion within 5 years tal’s principals have completed more than 300 corporate finance and $50 billion within 10 years.
    [Show full text]
  • MARIJUANA PREVENTION STRATEGIES RESOURCE GUIDE Marijuana Prevention Strategies Resource Guide
    MARIJUANA PREVENTION STRATEGIES RESOURCE GUIDE Marijuana Prevention Strategies Resource Guide Marijuana Prevention Strategies Resource Guide © Prevention First 2019. For reprint permission contact the Communications Department at 800.572.5385. © 2019, Prevention First Page 2 Marijuana Prevention Strategies Resource Guide Prevention First is a nonprofit dedicated to preventing teen drug use before it starts. Since 1980, Prevention First has provided training, technical assistance and resource materials to thousands of schools, community groups, parents and youth. We specialize in building the capacity of practitioners to develop strategic plans to address local substance abuse prevention needs, select and implement the best programs, curricula and strategies designed to promote social and emotional health and prevent substance abuse, and develop and implement media and communication campaigns designed to educate the public. Prevention First is primarily funded by the Illinois Department of Human Services Division of Substance Use Prevention and Recovery. Additional funding is provided by the Illinois Department of Corrections, Illinois Department of Transportation and through private foundations and individual donations. Our Vision Healthy communities that encourage drug-free youth. Our Mission To build community capacity to prevent substance abuse by providing training and technical assistance and raising public awareness. © 2019, Prevention First Page 3 Marijuana Prevention Strategies Resource Guide WELCOME This guide is intended to be a resource for prevention specialists, public health advocates and anyone involved in preventing youth marijuana use in Illinois. It focuses on strategies that are particularly relevant to counteract the potential impact of the Illinois Cannabis Regulation Tax Act. The legalization of recreational marijuana is similar to the legalization of alcohol that took place in the 1930’s and the time leading up to and including the passage of the National Minimum Drinking Age Act of 1984.
    [Show full text]
  • Concentrates: E Hottest Product Category in Cannabis Concentrates: the Hottest Product Category in Cannabis
    Concentrates: e Hottest Product Category in Cannabis Concentrates: The Hottest Product Category in Cannabis PUBLISHED BY IN PARTNERSHIP WITH THIS IS ONLY THECANNABIS EXECUTIVE INTELLIGENCESUMMARY BRIEFING Order the full report at shop.bdsanalytics.com TABLE OF CONTENTS 1 03 | Letter from the Editor Acknowledgements 04 | Executive Summary 05 | The Rapid Rise of Concentrates The Opportunity 08 | Concentrating Cannabis Profits Extraction Methods: 20 | Get More Product from the Plant Product Brands 26| Bringing Branding Savvy to Cannabis Sales Who 34| Leading Industry Practices and Brands THIS IS ONLY THE EXECUTIVE SUMMARY Order the full report at shop.bdsanalytics.com Retail consumer appeal is propelling concentrates toward an estimated $8 billion in retail sales by 2022, outpacing growth in traditional flower sales LETTER FROM EDITOR 3 Letter from the Editor The reunion of technology and cannabis, after their 80- versus smoking that is also happening with tobacco year forced separation, has quickly yielded profitable consumption, and the concentrates revolution will results in the form of concentrates. A product category affect every aspect of the legal cannabis business. that was just 10% of legal sales in the United States in 2014, should amount to 27% of the market this year For consumers, it’s a discreet and healthier choice that after just a few years of advancements in extraction will likely make cannabis consumers of people who technology, battery miniaturization and optimization, would never dream of inhaling smoke. That will cause heating element development, and form-factor design. the category to represent ever more retail display space, and likely spawn vape-only stores and on-premises In our forecast model, concentrates grow to nearly consumption venues.
    [Show full text]
  • 2020 Global Report on Cannabis Policy
    2020 Global Report on Cannabis Policy October 2020 2 i Contents INTRODUCTION II U.S.A. - OREGON 101 BRAZIL 1 U.S.A. - WASHINGTON 106 CANADA 12 OUR MEMBERS 111 CHINA 20 CONTRIBUTORS 112 COLOMBIA 25 DENMARK 31 ENGLAND 37 GERMANY 45 ITALY 51 PARAGUAY 56 PERU 60 SLOVENIA 68 SOUTH AFRICA 74 SPAIN 79 THAILAND 85 URUGUAY 90 U.S.A. - CALIFORNIA 96 Global Report on Cannabis Policy theworldlawgroup.com 3 ii WLG CANNABIS GUIDE INTRODUCTION We are very pleased to announce the release of the World Law Group (“WLG”) Cannabis Guide 2020. In recent years, cannabis and products with cannabis components are one of the “hot topics” in the life sciences industry. Many countries now allow the medical use of cannabis to treat numerous conditions, including chronic pain, cancer, multiple sclerosis, and many others. Additionally, more and more countries have recently allowed the recreational use of cannabis. Finally, hemp (cannabis grown without mind-altering substances), is another burgeoning industry worldwide. Though there are international treaties in place, the production, distribution, and consumption of controlled substances (including cannabis) are still traditionally regulated by each country individually (even within the EU). Some countries still consider cannabis a dangerous illicit substance. Thus the legal landscape on cannabis and cannabis products is very fragmented and complicated, making it hard to get involved in the cannabis industry. The aim of this guide is to provide a brief overview of laws and policies regarding the use of cannabis in various jurisdictions. It briefly outlines information on the most important legal issues, from relevant legislation and general information to special requirements and risks.
    [Show full text]